Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
COHR · NYSE · United States · Optical Instruments & Lenses
In shortCOHERENT CORP. is profitable, burns cash and carries moderate debt, with revenue growing (+22.5% last year).
Financial health
Solid
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | – | n/a |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | 11.3% | 65/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | 9.7% | 49/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | – | n/a |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 2.43× | 100/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 0.30× | 95/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | – | n/a |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | – | n/a |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | – | n/a |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | -14.4% | 0/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | -1.27× | 0/100 |
| Years with positive free cash flow (last 5) | 4 of 5 | 75/100 |
Weight in the score: 20%
| Profitable years (last 5) | 3 of 5 | 60/100 |
|---|---|---|
| Years of revenue decline (last 5) | 1 of 5 | 67/100 |
| Revenue growth volatility | 23.9% | 23/100 |
| Operating margin volatility | 7.0% | 46/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | 11.3% | 80/100 |
|---|---|---|
| EPS growth, 3-year average | – | n/a |
Weight in the score: 10%
Fiscal year 2026 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
5 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 3,317 | 5,160 | 4,708 | 5,810 | 7,118 |
| Cost of revenue | 2,051 | 3,542 | 3,252 | 3,767 | 4,449 |
| Gross profit | 1,265 | 1,618 | 1,456 | 2,043 | 2,669 |
| Research & development | 377 | 500 | 479 | 582 | 723 |
| Selling, general & admin | 474 | 1,037 | 854 | 926 | 1,045 |
| Operating income | 414 | (37) | 96 | – | – |
| Interest expense | 121 | 287 | – | – | – |
| Pre-tax income | 282 | (356) | (148) | 94 | 848 |
| Income tax | 47 | (96) | 11 | 64 | 61 |
| Net income | 235 | (259) | (156) | 49 | 805 |
| Diluted EPS | $1.45 | −$2.93 | −$1.84 | −$0.52 | $4.12 |
| Diluted shares (millions) | 117 | 138 | 152 | 155 | 195 |
5 older years available with the 10-year history. Essential plan, from €8.25/month →
Not computed: a required balance-sheet item is missing.
6/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Jun 30, 2026 · Data updated Aug 14, 2026